LOMBARD MED INC - COM (EVAR)

CUSIP: G55598109

Q3 2014 13F Holders as of 30 Sep 2014

Type / Class
Equity / COM
Total 13F shares
4,941,601
Share change
+3,251,782
Total reported value
$37,867,131
Price per share
$7.69
Number of holders
17
Value change
+$24,947,035
Number of buys
9
Number of sells
7

Quarterly Holders Quick Answers

What is CUSIP G55598109?
CUSIP G55598109 identifies EVAR - LOMBARD MED INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of LOMBARD MED INC - COM (EVAR) as of Q3 2014

As of 30 Sep 2014, LOMBARD MED INC - COM (EVAR) was held by 17 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 4,941,601 shares. The largest 10 holders included Abingworth LLP, FIL Ltd, Citadel Advisors LLC, Alyeska Investment Group, L.P., MORGAN STANLEY, DEUTSCHE BANK AG\, GLG Partners LP, MOORE CAPITAL MANAGEMENT, LP, UBS OCONNOR LLC, and Verition Fund Management LLC. This page lists 17 institutional shareholders reporting positions in this security for the Q3 2014 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.